Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect

Clinical trial NCT03825510 · COMPLETED

Trial details

NCT number: NCT03825510
Sponsor: Crozer-Keystone Health System
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Nonsmall Cell Lung Cancer Non Small Cell Lung Cancer

Start date: 2017-04-28
Primary completion: 2022-03-08
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.